Table 4.
Biometric evaluation: impact of disease activity.
| Measurement Device |
Mean IBD Patients in Remission (Std.Dev) |
Mean IBD Patients in Mild Activity (Std.Dev) |
Mean IBD Patients in Moderate Activity (Std.Dev) |
Mean IBD Patients in Severe Activity (Std.Dev) |
p | |
|---|---|---|---|---|---|---|
| Phase Angle | BIA | 5.919 (0.720) | 5.535 (1.254) | 5.244 (1.178) | 4.719 (1.080) | 0.0213 |
| Skeletal Muscle Mass | BIA | 30.706 (7.010) | 29.305 (5.750) | 27.216 (7.167) | 25.354 (9.131) | 0.1565 |
| SMI | BIA | 10.080 (1.620) | 10.041 (1.712) | 9.298 (2.165) | 9.759 (2.628) | 0.3993 |
| Appendicular Lean Mass | DEXA | 20.893 (4.716) | 17.400 (3.187) | 18.883 (4.174) | 11.768 (0.0001) | 0.0221 |
| ASMI | DEXA | 6.976 (1.142) | 6.252 (0.957) | 6.732 (1.117) | 5.636 (0.0001) | 0.1489 |
Abbreviations. IBD: Inflammatory Bowel Disease; DEXA: Dual Energy X-ray Absorptiometry; BIA: Bio-Impedensometric Analysis. SMI: Skeletal Muscle Index; ASMI: Appendicular Skeletal Mass Index.